1. Home
  2. DOMO vs RCEL Comparison

DOMO vs RCEL Comparison

Compare DOMO & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Domo Inc. Class B

DOMO

Domo Inc. Class B

HOLD

Current Price

$8.66

Market Cap

477.0M

Sector

Technology

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$3.34

Market Cap

114.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOMO
RCEL
Founded
2010
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
477.0M
114.3M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
DOMO
RCEL
Price
$8.66
$3.34
Analyst Decision
Buy
Buy
Analyst Count
8
5
Target Price
$14.38
$11.75
AVG Volume (30 Days)
918.6K
196.2K
Earning Date
12-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$318,002,000.00
$72,401,000.00
Revenue This Year
$2.32
$13.12
Revenue Next Year
$2.72
$27.56
P/E Ratio
N/A
N/A
Revenue Growth
N/A
20.59
52 Week Low
$6.01
$3.33
52 Week High
$18.49
$14.16

Technical Indicators

Market Signals
Indicator
DOMO
RCEL
Relative Strength Index (RSI) 27.29 33.79
Support Level $8.40 $3.33
Resistance Level $9.27 $3.58
Average True Range (ATR) 0.55 0.18
MACD -0.10 0.00
Stochastic Oscillator 6.75 13.24

Price Performance

Historical Comparison
DOMO
RCEL

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: